Literature DB >> 18202755

Expression of p16INK4a and MIB-1 in relation to histopathology and HPV types in cervical adenocarcinoma.

Susanne Muller1, Carmen Flores-Staino, Barbro Skyldberg, Ann-Cathrin Hellström, Bo Johansson, Bjorn Hagmar, Keng-Ling Wallin, Sonia Andersson.   

Abstract

A total of 101 primary cervical adenocarcinomas were analyzed for the presence of p16INK4a and MIB-1 expression in correlation with the presence of 'high-risk' types of human papillomavirus (HR-HPV) and clinical outcome. We found that adenocarcinoma grading showed a significant negative correlation to p16INK4a levels (p=0.001): i.e. we found less intense p16 staining in poorly differentiated tumors than in more highly differentiated tumors as well as a highly significant correlation between HPV infection and higher levels of p16INK4a staining (p=0.00), which was similar for different HPV-types. Tumor suppressor protein p16INK4a levels were higher in HPV positive than in HPV negative tumors. Higher levels of the proliferation marker MIB-1 were associated with poorer outcome. Higher MIB-1 levels were seen in tumors with a lower grade and higher stage at diagnosis. Moreover, MIB-1 levels seem to be higher in tumors due to infection with HPV 16 and 18 compared with HPV 45. MIB-1 may be a helpful marker in grading adenocarcinoma: a high level of expression of MIB-1 indicates a low grade of tumor, whereas high expression of p16INK4a indicates a highly differentiated of the tumor. Thus, immunostaining for p16INK4a appears to be a useful diagnostic tool for cervical adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202755

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  High-risk HPV E6/E7 mRNA in situ hybridization in endocervical glandular neoplasia: performance compared with p16INK4a and Ki67 immunochemistry.

Authors:  Tingting Chen; Jing Li; Shunni Wang; Yan Ning; Xianrong Zhou; Yiqin Wang
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

Review 2.  Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.

Authors:  Sandra Lee; Marianne S Rose; Vikrant V Sahasrabuddhe; Rachel Zhao; Máire A Duggan
Journal:  Int J Gynecol Pathol       Date:  2017-07       Impact factor: 2.762

3.  Comparison of human papillomavirus detection between freshly frozen tissue and paraffin embedded tissue of invasive cervical cancer.

Authors:  Michael Odida; Silvia de Sanjose; Sven Sandin; Beatriz Quiros; Laia Alemany; Belen Lloveras; Wim Quint; Bernhard Kleter; Maria Alejo; Leen-Jan van Doorn; Elisabete Weiderpass
Journal:  Infect Agent Cancer       Date:  2010-09-16       Impact factor: 2.965

4.  Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix.

Authors:  Shi-Wen Zhang; Rong-Zhen Luo; Xiao-Ying Sun; Xia Yang; Hai-Xia Yang; Si-Ping Xiong; Li-Li Liu
Journal:  BMC Cancer       Date:  2021-03-31       Impact factor: 4.430

5.  Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina.

Authors:  K Hellman; D Lindquist; C Ranhem; E Wilander; S Andersson
Journal:  Br J Cancer       Date:  2014-02-13       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.